急性粒细胞型白血病(简称急粒)的治疗虽有一定改善,但其预后仍然不佳。通过化疗不能获得缓解的患者通常在几周内死亡。许多研究表明:获得缓解的大多数患者只能存活一年左右。疗效肯定不如儿童的急淋患者。急粒的近代治疗、化疗几乎肯定会造成骨髓再生障碍及明显的毒性反应。但应看到治疗上的进展,表现缓解率的增加及相当多的患者已能存活二年以上。 Acute myeloid leukemia (referred to as acute particles) although the treatment has improved, but its prognosis is still poor. Patients who can not be relieved by chemotherapy usually die within a few weeks. Many studies show that most patients who are remitted will survive only about a year. Curative effect certainly not as good as children’s acute lymph nodes. Modern medicine acute treatment, chemotherapy will almost certainly cause bone marrow regeneration disorders and significant toxicity. However, treatment progress should be seen, with an increase in response rates and a considerable number of patients who have survived for more than two years.